Matteo Levisetti
Chief Tech/Sci/R&D Officer at CUE BIOPHARMA, INC.
Net worth: 17 445 $ as of 2024-03-30
Profile
Matteo Levisetti's career history includes current and former positions as well as his education.
Currently, he is the Chief Medical Officer at Cue Biopharma, Inc. Prior to this, he held the position of Chief Medical Officer at DNAtrix, Inc. from 2019 to 2021.
Additionally, he served as the Executive Director-Clinical Development at Mirati Therapeutics, Inc. from 2016 to 2017 and as the Chief Medical Officer at Dauntless Pharmaceuticals, Inc. from 2017 to 2018.
He also worked as the Global Head & VP-Translational Medicine at Roche Pharmaceuticals, Inc. Furthermore, he has experience as an Assistant Professor at Washington University School of Medicine.
Dr. Levisetti obtained his doctorate degree from Pritzker School of Medicine in 1996.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CUE BIOPHARMA, INC.
0.02% | 2024-03-05 | 9,230 ( 0.02% ) | 17 445 $ | 2024-03-30 |
Matteo Levisetti active positions
| Companies | Position | Start |
|---|---|---|
| CUE BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 2021-02-21 |
Former positions of Matteo Levisetti
| Companies | Position | End |
|---|---|---|
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 2020-12-31 |
Dauntless Pharmaceuticals, Inc.
 Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 2018-05-31 |
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2017-04-30 |
| Washington University School of Medicine | Corporate Officer/Principal | - |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Training of Matteo Levisetti
| Pritzker School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CUE BIOPHARMA, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA. | Retail Trade |
- Stock Market
- Insiders
- Matteo Levisetti